Alantos Pharmaceuticals Holding, Inc.
Biopharmaceutical company raises $20M in private placement
Published in Medical Device Business Week, April 6th, 2005
Proceeds from the financing will be used to progress the company's pipeline of compounds, particularly its two lead candidates for diabetes and osteoarthritis into clinical development.
Alantos also announced the appointment of Frank L. Douglas, MD, PhD, as chairman of the board. Until September 2004, Douglas was Executive VP of Aventis Pharma AG and head of Drug Innovation and Approval, with responsibilities for worldwide...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week
More Articles from Medical Device Business Week
- A.P. Pharma, Inc.
Pharmaceutical firm reports 11% increase in revenues, provides clinical update - AVI BioPharma, Inc.
Biotech firm reports loss of $0.14 per share - Able Laboratories, Inc.
Pharmaceutical firm reports 54.7% increase in gross profits - Adolor Corporation
Biopharmaceutical firm reports loss of $1.12 per share - Aksys, Ltd.
Dialysis product maker reports loss of $0.26 per share - Altachem Pharma, Ltd.
Pharmaceutical firm closes first tranche of private placement - More from this issue of Medical Device Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
